What is he best known for?
The fields of study he is best known for:
- Psychiatry
- Internal medicine
- Major depressive disorder
His primary areas of study are Psychiatry, Meta-analysis, Randomized controlled trial, Depression and Physical therapy.
Simon Gilbody has researched Psychiatry in several fields, including Relative risk and Confidence interval.
His Meta-analysis study incorporates themes from Odds ratio, Observational study, Psychological intervention and Clinical psychology.
His work carried out in the field of Randomized controlled trial brings together such families of science as Psychopharmacology and Clinical trial.
His research in Depression intersects with topics in Intervention, Alternative medicine, Primary care and Mass screening.
His Physical therapy course of study focuses on Severity of illness and Psychiatric status rating scales.
His most cited work include:
- Collaborative care for depression: a cumulative meta-analysis and review of longer-term outcomes. (1053 citations)
- Screening for Depression in Medical Settings with the Patient Health Questionnaire (PHQ): A Diagnostic Meta-Analysis (722 citations)
- Optimal cut-off score for diagnosing depression with the Patient Health Questionnaire (PHQ-9): a meta-analysis (714 citations)
What are the main themes of his work throughout his whole career to date?
Simon Gilbody spends much of his time researching Psychiatry, Depression, Mental health, Randomized controlled trial and Psychological intervention.
His research on Psychiatry often connects related topics like Relative risk.
His biological study deals with issues like Meta-analysis, which deal with fields such as Clinical trial.
His work deals with themes such as Nursing, Public health, Primary care, Family medicine and Cohort, which intersect with Mental health.
As part of the same scientific family, Simon Gilbody usually focuses on Randomized controlled trial, concentrating on Physical therapy and intersecting with Odds ratio and Major depressive disorder.
His work carried out in the field of Psychological intervention brings together such families of science as PsycINFO, Social support and Gerontology.
He most often published in these fields:
- Psychiatry (41.44%)
- Depression (35.88%)
- Mental health (30.32%)
What were the highlights of his more recent work (between 2018-2021)?
- Psychological intervention (25.00%)
- Depression (35.88%)
- Mental health (30.32%)
In recent papers he was focusing on the following fields of study:
Psychological intervention, Depression, Mental health, Randomized controlled trial and Meta-analysis are his primary areas of study.
The various areas that Simon Gilbody examines in his Depression study include PsycINFO, Physical therapy, Internal medicine and Primary care.
His Physical therapy research includes elements of Odds ratio and Patient Health Questionnaire.
His Mental health research is classified as research in Psychiatry.
In his research, Adverse effect is intimately related to Placebo, which falls under the overarching field of Randomized controlled trial.
Simon Gilbody has researched Meta-analysis in several fields, including Mini-international neuropsychiatric interview, Cognitive behavioral therapy and Clinical psychology.
Between 2018 and 2021, his most popular works were:
- Smoking cessation for people with severe mental illness (SCIMITAR+): a pragmatic randomised controlled trial (53 citations)
- The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomised trial (40 citations)
- Patient Health Questionnaire-9 scores do not accurately estimate depression prevalence: individual participant data meta-analysis (32 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Major depressive disorder
- Psychiatry
His main research concerns Meta-analysis, Psychological intervention, Depression, Randomized controlled trial and Patient Health Questionnaire.
The study incorporates disciplines such as Clinical psychology, Mini-international neuropsychiatric interview and Quality of life in addition to Meta-analysis.
His Psychological intervention study is concerned with Psychiatry in general.
His research integrates issues of Sexual abuse and Child abuse in his study of Psychiatry.
His studies deal with areas such as Collaborative Care, Adverse effect, First episode, Placebo and Sertraline as well as Randomized controlled trial.
His Patient Health Questionnaire study integrates concerns from other disciplines, such as Physical therapy and Confidence interval.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
